A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS
Annals of Internal MedicinePublished 1 November 1991
Alan G. Palestine, Michael A. Polis, Marc D. de Smet, Barbara Baird, J Falloon, Joseph A. Kovacs
Citations328
SJR quartileQ1
SJR score3.38
SNIP3.27
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The administration of foscarnet sodium decreases the rate of progression of cytomegalovirus retinitis in persons with AIDS and its judicious use is likely to prevent loss of vision in these patients.
Abstract
The administration of foscarnet decreases the rate of progression of cytomegalovirus retinitis in persons with AIDS. Its judicious use is likely to prevent loss of vision in these patients. In this study, however, there was little change in visual acuity in patients in either the immediate or delayed treatment group because only patients with non-sight-threatening disease were selected.
Keywords
Immunology and MicrobiologyMedicine
Annals of Internal MedicineSerious Cytomegalovirus Disease in the Acquired Immunodeficiency Syndrome (AIDS)
511 Citations1988Mark Z. Jacobson, JOHN MILLS
Based on limited data, foscarnet, a pyrophosphate analogue, also appears to have some efficacy in treating cytomegalovirus infection and, like ganciclovir, does not cause myelosuppression.
OphthalmologyAcquired Immune Deficiency Syndrome
452 Citations1985Jay S. Pepose, Gary N. Holland +3 more
A mechanism is proposed linking the deposition of immune complexes with subsequent small vessel lesions, ischemia, cotton-wool spots and later spread of cytomegalovirus to retina via damaged vascular endothelium.
New England Journal of MedicineTreatment of Serious Cytomegalovirus Infections with 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine in Patients with AIDS and Other Immunodeficiencies
429 Citations1986Collaborative DHPG Treatment Study Group
It is concluded that DHPG offers promise for the therapy of severe cytomegalovirus infections in some immunodeficient patients, but further study will be necessary to establish its efficacy and safety.
JAMAHerpesvirus Infections in the Acquired Immune Deficiency Syndrome
397 Citations1984Gerald V. Quinnan
The prevalence of EBV and CMV infections in AIDS and the chronic lymphadenopathy syndrome may be the result of an important interaction between these viruses and the cause of AIDS.
Pharmacology & TherapeuticsAntiviral effects of phosphonoformate (PFA, foscarnet sodium)
338 Citations1982Bo Öberg
OphthalmologyOphthalmic Involvement in Acquired Immunodeficiency Syndrome
312 Citations1984Alan G. Palestine, Merlyn M. Rodrigues +10 more
Twenty patients with acquired immunodeficiency syndrome (AIDS) died and the eyes were obtained for culture and histopathologic examination, and cytomegalovirus retinitis was a significant cause of visual loss.
American Journal of NephrologyFoscarnet Nephrotoxicity: Mechanism, Incidence and Prevention
222 Citations2008Gilbert Deray, Franck Martinez +9 more
Foscarnet is a highly nephrotoxic drug which induces acute tubular necrosis and in the group which was prospectively hydrated only 1 patient had an acute renal failure.
The LancetINHIBITION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE III IN VITRO BY PHOSPHONOFORMATE
219 Citations1985E G Sandstrom, RoyE. Byington +2 more
Phosphonoformate, an inhibitor of reverse transcriptase in a number of retroviruses, was shown to have a dose-related inhibitory effect on human T-cell lymphotropic virus type III (HTLV-III) replication in the H9 cell line in vitro.
American Journal of Clinical PathologyAcquired Immune Deficiency Syndrome: Postmortem Findings
208 Citations1984Luis A. Guarda, Mario A. Luna +4 more
Clinical Infectious DiseasesGanciclovir Treatment of Life- or Sight-Threatening Cytomegalovirus Infection: Experience in 314 Immunocompromised Patients
200 Citations1988William Buhles, B J Mastre +4 more
It was concluded that ganciclovir has clinical efficacy against CMV disease, as well as an in vivo antiviral effect, and that this agent reduces morbidity of serious CMV infections in immunocompromised patients.
Annals of Internal MedicineTreatment of Cytomegalovirus Retinitis with 9-[2-Hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine
197 Citations1985Donna Felsenstein, DONALD J. D'AMICO +5 more
The use of an acyclic nucleoside 9-[2-hydroxy-1-(hydroxymethyl) ethoxy methyl]guanine (BW B759U), in the treatment of two patients with cytomegalovirus retinitis, was evident, with healing of retinal lesions and resolution of viremia and viral shedding.
The American Journal of MedicineCorrelation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome
171 Citations1985H. Clifford Lane, Henry Masur +7 more
Those patients who present with opportunistic infections as their initial clinical manifestation of AIDS may represent a subgroup with a more severe immunologic derangement prior to clinical diagnosis, and this finding is of importance in attempts to understand the pathogenesis of this syndrome.
The Journal of Infectious DiseasesTreatment of Cytomegalovirus Retinitis with Trisodium Phosphonoformate Hexahydrate (Foscarnet)
157 Citations1988Sharon Walmsley, Emily Y. Chew +5 more
Antimicrobial Agents and ChemotherapyFoscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome
154 Citations1989Mark Z. Jacobson, James J. O’Donnell +1 more
Intermittently administered intravenous foscarnet appears to be an effective, relatively nontoxic therapy for CMV retinitis and additional studies to determine the optimal dosage for maintenance therapy are needed.
Annals of Internal MedicineEffect of 9-(1,3-Dihydroxy-2-Propoxymethyl) Guanine on Serious Cytomegalovirus Disease in Eight Immunosuppressed Homosexual Men
150 Citations1986Henry Masur, H. CLIFFORD LANE +18 more
8 immunosuppressed homosexual men with cytomegalovirus viremia treated with a new acyclovir derivative, 9-(1,3-dihydroxy-2-propoxymethyl) guanine, had virologic and clinical improvement, but substantial leukopenia developed in three patients, suggesting more effective and less toxic therapeutic regimens for both acute and chronic use must be developed.
American Journal of OphthalmologyTreatment of Cytomegalovirus Retinitis With Dihydroxy Propoxymethyl Guanine
135 Citations1986Alan G. Palestine, Garth Stevens +11 more
Dihydroxy propoxymethyl guanine appears to be effective biologically in treating human cytomegalovirus retinitis without the development of unacceptable side effects but a single course of therapy is not capable of eradicating the virus.
Annals of Internal MedicineToxicity of Combined Ganciclovir and Zidovudine for Cytomegalovirus Disease Associated with AIDS
130 Citations1990Howard S. Höchster, Douglas T. Dieterich +9 more
The combination of zidovudine and ganciclovir is poorly tolerated in patients with AIDS and serious-CMV disease, with 82% developing severe to life-threatening hematologic toxicity.
Antimicrobial Agents and ChemotherapySynergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro
126 Citations1990Jody Manischewitz, Gerald V. Quinnan +2 more
It is demonstrated synergistic inhibition of cytomegalovirus replication in vitro by ganciclovir and foscarnet and reduced-dose combination therapy may provide a means to treat patients with cytomeGalovirus infection while reducing drug toxicity.
OphthalmologyFoscarnet in the Treatment of Cytomegalovirus Retinitis in Acquired Immune Deficiency Syndrome
124 Citations1989Phuc LeHoang, Brigitte Girard +12 more
Foscarnet appears to be a useful alternative to ganciclovir, particularly when combined with bone marrow toxic drugs, such as zidovudine (azidothymidine), which produced kidney toxicity that led to reversible renal insufficiency in three cases.
Annals of Internal Medicine9-(1,3-dihydroxy-2-propoxymethyl)guanine for Cytomegalovirus Infections in Patients with the Acquired Immunodeficiency Syndrome
114 Citations1985Michael C. Bach, SANDRA P. BAGWELL +3 more
Dseminated cytomegalovirus infection is a major cause of mortality in patients with the acquired immuno-deficiency syndrome as well as in other immunosuppressed patients including bon...
PubMedImmediate causes of death in acquired immunodeficiency syndrome.
100 Citations1985Lee B. Moskowitz, G T Hensley +2 more
Evidence is provided that 42% of adults who underwent an autopsy and were diagnosed as having died of the acquired immunodeficiency syndrome between April 1980 and October 1983 died of currently untreatable diseases.
Antimicrobial Agents and ChemotherapyCombinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro
89 Citations1989B. Eriksson, Raymond F. Schinazi
The synergistic interactions in infected cells and the additive effects observed at thereverse transcriptase level indicate that mechanisms other than the reverse transcriptase may be of importance for the inhibition of human immunodeficiency virus replication by these two compounds.
Antiviral ResearchIncreased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo
73 Citations1989Vicki R. Freitas, E B Fraser-Smith +1 more
Results suggest an additive interaction between the two drugs in vivo between either murine CMV or HSV-2 and the acyclic nucleoside ganciclovir and 3-fold for foscarnet when the 2 drugs were combined.
IntervirologyReversible Inhibition of Cytomegalovirus Replication by Phosphonoformate
61 Citations1980Britta Wahrén, Bo Ouml berg
The results suggest that the input CMV genome persists in most initially infected cells, survives PFA incubation, and is active again after PFA release, which differs from abortive CMV infections.
JAIDS Journal of Acquired Immune Deficiency SyndromesFoscarnet Therapy of Cytomegalovirus Retinitis in AIDS
54 Citations1990Mary M. Fanning, Stanley Read +13 more
Foscarnet therapy did not lead to suppression of urinary excretion of CMV in four of 12 patients who nonetheless had improvement in retinal lesions and drug levels during continuous infusion were stable for individual patients but showed wide inter-patient variability.
PubMedThe effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients.
44 Citations1987Janne E. Gaub, Carsten Bøcker Pedersen +8 more
Renal function impairment limits foscarnet use in AIDS patients, but in individuals with less severe manifestations of HIV infection, this side effect may be less frequent.
PubMedPhosphonoformate (foscarnet): a pilot study in AIDS and AIDS related complex.
33 Citations1987Farthing Cf, Dalgleish Ag +4 more
It is suggested that a further trial with PFA administered over a longer period and with a longer follow-up period in AIDS and ARC patients may be warranted, particularly if an oral preparation becomes available.